UnitedHealth Group (UNH) PT Raised to $600 at Argus
Argus analyst David Toung raised the price target on UnitedHealth Group (NYSE: UNH) to $600.00 (from $570.00) while maintaining a Buy rating.
The analyst comments "We are reaffirming our BUY rating on UnitedHealth Group Inc. (NYSE: UNH) with a raised price target of $600, up from $570. Despite weathering a cyberattack that led to a temporary shutdown of the Change Healthcare claims processing and payments network, the UnitedHealthcare and Optum segments delivered strong revenue growth. Medical utilization trends remain within expectations. Double-digit top-line increases at Optum Health (+13%) and Optum Rx (+13%), along with solid growth in backlog at Optum Insight should drive revenue and earnings growth in the health services segment in 2024."